ENDOCRINE PHARM REVIEW Flashcards
(45 cards)
Desmopressin
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Desmopressin
Central Diabetes Insipidus. Also used diagnostically
Recombinant AVP; stimulates V2R
-
Can be given IV/SC/PO, usually twice daily
Conivaptan/Talvaptan
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Conivaptan/Talvaptan
SIADH management
Blocks V2R to reduce AQ2 translocation.
Rare association with liver failure
-
Demeclocycline
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Demeclocycline
SIADH management
Inhibits the collecting tubules response to AVP
Nephrotoxic (rarely used)
Takes up to one week to be effective.
hGH
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
hGH
GH deficiency (eg short stature)
Recombinant growth hormone…
Rare: SCFE, scoliosis, pseudotumor cerebri, apnea
Give each evening, subQ.
Cabergoline
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Cabergoline
Hyperprolactinemia. Adjunct for acromegaly, secondary Cushing’s…
Agonizes dopamine receptors, downregulating prolactin
N/V, orthostatic hypotension, rare cardiac valvulopathy in Parkinson’s patients.
Better half life, affinity, (everything) than bromocriptine.
Bromocriptine
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Bromocriptine
Hyperprolactinemia (1st trimester pregnancies)
Dopamine agonist, downregulates prolactin
As cabergoline, but generally worse.
Shorter half-life, requires frequent dosing.
Octreotide/Lanreotide
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Octreotide/Lanreotide
Acromegaly.
Somatostatin agonist, decreases GH secretion.
Diarrhea, abdominal cramping, flatulence, cholelithiasis.
-
Pegvisomant
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Pegvisomant
(refractory) Acromegaly.
GH receptor antagonist (mainly at liver)
Transient liver panel elevation, tumor growth
-
Megestrol Acetate
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Megestrol Acetate
Cachexia of cancer patients
Progesterone compound, suppresses ACTH and cortisol. Stimulates appetite, apparently.
-
-
Mifepristone
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Mifepristone
Primary Cushing’s disease
Glucocorticoid receptor antagonist. (Note: may precipitate adrenal insufficiency)
-
-
Hydrocortisone
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Hydrocortisone
Primary > secondary adrenal insufficiencies.
Exogenous glucocorticoid…
See Cushing’s syndrome.
Can be given orally (daily). Give IM/IV in acute crisis or pre-op.
Fludrocortisone
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Fludrocortisone
Primary (not secondary!) adrenal insufficiency.
Exogenous mineralocorticoid…
See hyperaldosteronism
Take daily, monitor plasma renin.
Pasireotide
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Pasireotide
Secondary Cushing’s syndrome (refractory to surgery)
Somatostatin analog; reduces ACTH secretion.
Numerous side effects: diarrhea, nausea, hyperglycemia, headache…
-
Ketoconazole
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Ketoconazole
Primary Cushing’s syndrome
Adrenal steroidogenesis inhibitor
Liver toxicity
-
Metyrapone
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Metyrapone
Primary Cushing’s syndrome
Adrenal steroidogenesis inhibitor (11-beta hydroxylase inhibitor)
-
-
Mitotane
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Mitotane
Primary Cushing’s diseease (due to carcinoma)
Adrenal steroidogenesis inhibitor, lytic in high doses.
-
-
Etomidate
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Etomidate
Primary Cushing’s disease (especially in critically ill)
Adrenal steroidogenesis inhibitor
-
-
Spironolactone & Eplerenone
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Spironolactone & Eplerenone
Primary hyperaldosteronism.
Mineralocorticoid receptor antagonists.
Hyperkalemia…
-
Amiloride & Triamterene
Indication?
Mechanism of action?
Side effects / contraindications?
Kinetic considerations?
Amiloride & Triamterene
Liddle’s syndrome
Blocks the ENaC channel (downstream of spirono/eplerenone)
-
-
Phenoxybenzamine
Indication?
Mechanism of action?
Side effects & contraindications?
Kinetic considerations?
Phenoxybenzamine
Pheochromocytoma, notably pre-operatively.
Irreversibly blocks alpha receptors.
Orthostatic hypotension (a good goal for pre-op)
-
Calcitonin
Indication?
Mechanism of action?
Side effects & contraindications?
Kinetic considerations?
Calcitonin
Treatment of hypercalcemia, osteomalacia, Paget’s disease…(last resort)
Reduce osteoclast activity (weak!)
-
Tachyphylaxis.
Bisphosphonates
Indication?
Mechanism of action?
Side effects & contraindications?
Kinetic considerations?
Bisphosphonates
Treatment of hypercalcemia, osteoporosis, osteomalacia, Paget’s…
Induce osteoclast apoptosis by blocking farnesyl synthesis
Esophageal irritation (oral), acute phase reaction, femoral fractures, jaw osteonecrosis.
Ibandronate & Aledronate are oral, Pamedronate and Zanidronic acid are IV (more potent)
Cinacalcet
Indication?
Mechanism of action?
Side effects & contraindications?
Kinetic considerations?
Cinacalcet
Treatment of hypercalcemia, hyperparathyroidism
Calcimimetic which downregulates PTH production.
-
-
Calcium Gluconate
Indication?
Mechanism of action?
Side effects & contraindications?
Kinetic considerations?
Calcium Gluconate
Acute hypocalcemia.
Just replacement calcium…
-
Given IV.